Cysteine 144 is a key residue in the copper reduction by the beta-amyloid precursor protein

J Neurochem. 1999 Sep;73(3):1288-92. doi: 10.1046/j.1471-4159.1999.0731288.x.

Abstract

The beta-amyloid precursor protein (beta-APP) contains a copper-binding site localized between amino acids 135 and 156 (beta-APP(135-156)). We have employed synthetic beta-APP peptides to characterize their capacities to reduce Cu(II) to Cu(I). Analogues of the wild-type beta-APP(135-156) peptide, containing specific amino acid substitutions, were used to establish which residues are specifically involved in the reduction of copper by beta-APP(135-156). We report here that beta-APP's copper-binding domain reduced Cu(II) to Cu(I). The single-mutant beta-APP(His147-->Ala) and the double-mutant beta-APP(His147-->Ala/His149-->Ala) showed a small decrease in copper reduction in relation to the wild-type peptide and the beta-APP(Cys144-->Ser) mutation abolished it, suggesting that Cys144 is the key amino acid in the oxidoreduction reaction. Our results confirm that soluble beta-APP is involved in the reduction of Cu(II) to Cu(I).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Amyloid beta-Protein Precursor / chemistry*
  • Copper / chemistry*
  • Cysteine / chemistry*
  • Humans
  • Mutation
  • Oxidation-Reduction
  • Peptide Fragments / chemistry
  • Potentiometry

Substances

  • Amyloid beta-Protein Precursor
  • Peptide Fragments
  • Copper
  • Cysteine